NDC 46708-213

Amlodipine besylate and Olmesartran medoxomil

Amlodipine Besylate And Olmesartran Medoxomil

Amlodipine besylate and Olmesartran medoxomil is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Limited. The primary component is Amlodipine Besylate; Olmesartan Medoxomil.

• Product ID: 46708-213_a1a8dc29-8581-4c8f-a1da-1f36587796a7
• NDC: 46708-213
• Product Type: Human Prescription Drug
• Proprietary Name: Amlodipine besylate and Olmesartran medoxomil
• Generic Name: Amlodipine Besylate And Olmesartran Medoxomil
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2017-07-18
• Marketing Category: ANDA / ANDA
• Application Number: ANDA207073
• Labeler Name: Alembic Pharmaceuticals Limited
• Substance Name: AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
• Active Ingredient Strength: 5 mg/1; mg/1
• Pharm Classes: Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 46708-213-30

30 TABLET, FILM COATED in 1 BOTTLE (46708-213-30)

• Marketing Start Date: 2017-07-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 46708-213-30 [46708021330]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-07-18

NDC 46708-213-91 [46708021391]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-07-18

NDC 46708-213-90 [46708021390]

Amlodipine besylate and Olmesartran medoxomil TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA207073
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-07-18

Drug Details

Active Ingredients

Ingredient	Strength
AMLODIPINE BESYLATE	5 mg/1

OpenFDA Data

• SPL SET ID: cb2df7f7-fee8-42ba-8936-0788c4fcc0cb
• Manufacturer:
  • Alembic Pharmaceuticals Limited
• UNII:
  • 6M97XTV3HD
  • 864V2Q084H
• RxNorm Concept Unique ID - RxCUI:
  • 730872
  • 730861
  • 730866
  • 730869
• UPC Code:
  • 0346708214302
  • 0346708215309
  • 0346708213305
  • 0346708212308

Pharmacological Class

• Calcium Channel Antagonists [MoA]
• Dihydropyridine Calcium Channel Blocker [EPC]
• Dihydropyridines [CS]
• Angiotensin 2 Receptor Antagonists [MoA]
• Angiotensin 2 Receptor Blocker [EPC]

NDC Crossover Matching brand name "Amlodipine besylate and Olmesartran medoxomil" or generic name "Amlodipine Besylate And Olmesartran Medoxomil"

NDC	Brand Name	Generic Name
46708-212	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-213	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-214	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
46708-215	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-212	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-213	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-214	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil
62332-215	Amlodipine besylate and Olmesartran medoxomil	Amlodipine besylate and Olmesartran medoxomil